Vaccine effectiveness
Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Ethical and Scientific Considerations for Mpox Vaccination Programs in Africa
Reference: Edeling, H. (2024). Ethical and scientific considerations for Mpox vaccination programs in Africa. SAVIMS. Summary: The article by Dr. Herman Edeling discusses critical ethical and scientific considerations surrounding Mpox vaccination programmes in Africa. It highlights the need for comprehensive clinical assessments and accurate differential diagnoses for blistering skin disorders, emphasising the limitations of current
Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Concerns Over Emergency Monkeypox Vaccine Rollout in Africa
Reference: SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za Summary: The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced
Epidemiological surveillance, Monkeypox, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses
Comprehensive Global Response to Mpox Outbreaks
Reference: World Health Organization. (2024). Mpox global strategic preparedness and response plan. Geneva, Switzerland: Author. Retrieved from https://www.who.int/emergencies/en Summary: The World Health Organization’s Mpox Global Strategic Preparedness and Response Plan (2024) outlines a comprehensive approach to mitigate the resurgence of mpox outbreaks, especially in regions like the Democratic Republic of the Congo (DRC). Following the
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Critical Review of COVID-19 mRNA Vaccines: Safety and Efficacy Concerns
Reference: Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 mRNA vaccines: Lessons learned from the registrational trials and global vaccination campaign. Cureus, 16(1), e52876. https://doi.org/10.7759/cureus.52876 Summary: The article critically examines the safety and efficacy of COVID-19 mRNA vaccines, highlighting significant concerns regarding trial methodologies